PTSD Trial, Recruiting NCT06175104 Sponsor: Children's Hospital Medical Center, Cincinnati Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06175104
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The pregnancy involves a baby diagnosed with a heart condition where only one of the heart's two main pumping chambers has developed properly (called single ventricle congenital heart disease).
  • This heart condition was identified between 16 and 30 weeks of pregnancy.
  • The pregnancy involves only one baby (not twins or more).
  • The pregnant person is planning to continue with the pregnancy.
  • The pregnant person is able to take part in and complete study activities in English.

Who may not be able to join:

  • The baby has been diagnosed with an additional condition that is known to affect brain development (for example, DiGeorge Syndrome).
  • The baby or the pregnant person has a medical condition that the treating doctor determines would make trial participation unsafe or unsuitable (confirm with trial site).
  • A parent has an untreated serious mental health condition, a substance use disorder, or other circumstances that could affect safe or full participation in the trial.
  • A parent has a moderate to severe intellectual disability.
  • A parent is under 18 years of age.
  • The pregnancy involves a surrogate.

Note: If corticosteroids are given during pregnancy to help the baby's lungs develop, this does not affect eligibility — the treating team will simply record that this occurred.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nadine A. Kasparian, PhD, Children's Hospital Medical Center, Cincinnati

Phone: 513-636-5575

Australian sites

Sydney Children's Hospital, Randwick, New South Wales
The Children's Hospital at Westmead, Westmead, New South Wales

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 July 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇦🇺 Australia 🇺🇸 United States

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Maternal anxiety symptoms; Maternal depressive symptoms; Maternal traumatic stress symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov